Melanie Orben, APRN
Psychiatric/Mental Health · Naples, FLNPI 1669982377
Payments from drug & device makers
Across 600 payments — averaging $31.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$12K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Ironshore Pharmaceuticals Inc.$532
- Johnson & Johnson$529
- Lundbeck LLC$515
- plus $3K from 20 others
What the payments were for
- Consulting fees$6804%
- Speaking & faculty fees$9,52050%
- Food & beverage$8,92347%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 177 | $11,902 |
| AbbVie | 82 | $1,452 |
| Otsuka America Pharmaceutical, Inc. | 64 | $1,223 |
| Ironshore Pharmaceuticals Inc. | 61 | $532 |
| Johnson & Johnson | 26 | $529 |
| Lundbeck LLC | 31 | $515 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $460 |
| Alkermes, Inc. | 22 | $395 |
| Axsome Therapeutics, Inc. | 15 | $327 |
| Corium, LLC | 15 | $295 |
| Neurocrine Biosciences, Inc. | 7 | $220 |
| Tempus AI, Inc | 12 | $217 |
| Almatica Pharma LLC | 13 | $207 |
| Teva Pharmaceuticals USA, Inc. | 12 | $207 |
| Supernus Pharmaceuticals, Inc. | 5 | $133 |
| Sunovion Pharmaceuticals Inc. | 5 | $104 |
| Tris Pharma Inc | 5 | $88 |
| Merck | 3 | $68 |
| Adlon Therapeutics L.p. | 4 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Eisai Inc. | 2 | $35 |
| Bausch Health US, LLC | 2 | $33 |
| Livanova USA, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Neos Therapeutics, LP | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,128 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 50 | $88,682 |
| Abilify MaintenaAripiprazole | 19 | $52,901 |
| RexultiBrexpiprazole | 20 | $46,153 |
| VraylarCariprazine Hcl | 12 | $17,569 |
| VyvanseLisdexamfetamine Dimesylate | 25 | $9,517 |
| FetzimaLevomilnacipran Hcl | 17 | $8,894 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 119 | $6,717 |
| Paliperidone ErPaliperidone | 14 | $2,880 |
| Aripiprazole | 80 | $2,116 |
| Lamotrigine | 185 | $2,110 |
| Vilazodone Hcl | 24 | $1,887 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 51 | $1,776 |
| Quetiapine Fumarate | 57 | $1,546 |
| Lurasidone Hcl | 14 | $1,397 |
| Duloxetine Hcl | 43 | $1,315 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $1,223 | $99,05539 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $11,902 | $88,68250 claims |
| AbbVieVraylar, Fetzima | $1,452 | $26,46429 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $460 | $9,51725 claims |
| Almatica Pharma LLCSertraline Hcl | $207 | $33045 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Naples
- Sara AschebrookNaples$12K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.